Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Anastrozole
HER2 Positive Breast Carcinoma
Sun Yat-sen UniversityP3BB (68)
Aspirin
Vertebral Artery Dissection
London Health Sciences CentreP3BB (68)
Bendamustine
Indolent B-Cell Non-Hodgkin Lymphoma
Fox Chase Cancer CenterP3BB (68)
Benmelstobart
Non-Small Cell Lung Carcinoma
The Third Xiangya Hospital of Central South UniversityP3BB (68)
Bicalutamide
Prostate Adenocarcinoma
OHSU Knight Cancer InstituteP3BB (68)
Bortezomib
Childhood Acute Lymphoblastic Leukemia
Tanja Andrea GruberP3BB (68)
Busulfanum
Mixed Phenotype Acute Leukemia
Fred Hutchinson Cancer CenterP3BB (68)
Camustine
Non-Hodgkin Lymphoma
VIVUS LLCP3BB (68)
Camustine
Follicular Lymphoma
M.D. Anderson Cancer CenterP3BB (68)
Capecitabine
Intestinal Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3BB (68)
Carboplatin
Diffuse Large B-Cell Lymphoma
University of California, DavisP3BB (68)
Carboplatin
Female Reproductive System Disorder
Wenjun ChengP3BB (68)
Carboplatin
Kidney Cancer
Oliver JonasP3BB (68)
Carboplatin
Lung Disorder
Jiangmen Central HospitalP3BB (68)
Carboplatin
Melanoma
Rapa Therapeutics LLCP3BB (68)
Carboplatin
Cutaneous Melanoma
Immatics US, Inc.P3BB (68)
Carboplatin
Metastatic Melanoma
Rapa Therapeutics LLCP3BB (68)
Carboplatin
Neoplasm
Bristol-Myers SquibbP3BB (68)
Carboplatin
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
University of California, DavisP3BB (68)
Carboplatin
Neoplasm Of Thorax
Fundación GECPP3BB (68)
Carboplatin
Urothelial Carcinoma
Neonc Technologies, Inc.P3BB (68)
Celecoxib
Classic Familial Adenomatous Polyposis
Yonsei UniversityP3BB (68)
Cetuximab
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP3BB (68)
Cetuximab
Colon Adenocarcinoma
Merck Sharp & Dohme LLCP3BB (68)
Cis-Diamminedichloroplatinum Ii
Classic Hodgkin Lymphoma
Cairo UniversityP3BB (68)
Showing 3401 to 3425 of 42,285 assets
PreviousPage 137 of 1692Next